1. Home
  2. NKTR vs ECBK Comparison

NKTR vs ECBK Comparison

Compare NKTR & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • ECBK
  • Stock Information
  • Founded
  • NKTR 1990
  • ECBK 1919
  • Country
  • NKTR United States
  • ECBK United States
  • Employees
  • NKTR N/A
  • ECBK N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • ECBK Banks
  • Sector
  • NKTR Health Care
  • ECBK Finance
  • Exchange
  • NKTR Nasdaq
  • ECBK Nasdaq
  • Market Cap
  • NKTR 160.4M
  • ECBK 135.9M
  • IPO Year
  • NKTR 1994
  • ECBK N/A
  • Fundamental
  • Price
  • NKTR $0.74
  • ECBK $15.25
  • Analyst Decision
  • NKTR Strong Buy
  • ECBK
  • Analyst Count
  • NKTR 5
  • ECBK 0
  • Target Price
  • NKTR $5.50
  • ECBK N/A
  • AVG Volume (30 Days)
  • NKTR 1.4M
  • ECBK 10.6K
  • Earning Date
  • NKTR 03-12-2025
  • ECBK 04-24-2025
  • Dividend Yield
  • NKTR N/A
  • ECBK N/A
  • EPS Growth
  • NKTR N/A
  • ECBK N/A
  • EPS
  • NKTR N/A
  • ECBK 0.48
  • Revenue
  • NKTR $98,427,000.00
  • ECBK $26,040,000.00
  • Revenue This Year
  • NKTR N/A
  • ECBK N/A
  • Revenue Next Year
  • NKTR N/A
  • ECBK N/A
  • P/E Ratio
  • NKTR N/A
  • ECBK $31.88
  • Revenue Growth
  • NKTR 9.21
  • ECBK 4.00
  • 52 Week Low
  • NKTR $0.65
  • ECBK $11.39
  • 52 Week High
  • NKTR $1.93
  • ECBK $15.75
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 36.32
  • ECBK 62.87
  • Support Level
  • NKTR $0.84
  • ECBK $15.15
  • Resistance Level
  • NKTR $0.92
  • ECBK $15.39
  • Average True Range (ATR)
  • NKTR 0.08
  • ECBK 0.23
  • MACD
  • NKTR -0.01
  • ECBK -0.00
  • Stochastic Oscillator
  • NKTR 0.40
  • ECBK 80.03

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About ECBK ECB Bancorp Inc.

ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.

Share on Social Networks: